Strides Arcolab’s Q4 net jumps 30 fold

28 Feb 2012 Evaluate

Strides Arcolab has reported 30 fold rise in consolidated net profit after minority interest at Rs 68.4 crore for the fourth quarter ended December 2011 compared to Rs 2.2 crore reported in the corresponding quarter previous year. The company’s sales for the quarter were up by 50.60% at Rs 686.4 crore compared to the same period a year ago.

The reason for a big jump in profits is mainly on account of a strong performance of injectables and pharmaceuticals business.

The company has recommended dividend at Rs 2.00 per share for the year ended December 31, 2011.

Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterlite injectables.

Strides Pharma Scien Share Price

676.20 -8.10 (-1.18%)
23-Dec-2024 09:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1799.55
Dr. Reddys Lab 1338.20
Cipla 1467.95
Lupin 2140.70
Zydus Lifesciences 964.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.